PRECIPIO, INC. Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements
PRECIPIO, INC. (PRPO) reported Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements of 82.11 thousand shares for the 3-month period ending 2025-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Notes
us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements · last filed 2026-08-14
- PRECIPIO, INC. incremental common shares attributable to dilutive effect of share-based payment arrangements for the quarter ending 2025-06-30 was 82.11K shares.
| Period end | Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements 3 month |
|---|---|
| 2025-06-30 | 82.11K shares 10-Q · filed 2026-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |